scholarly journals The tyrosine kinase inhibitor dasatinib blocks tumour growth, invasion and recurrence potential by interrupting the communication between cancer cells and their surrounding microenvironment in triple negative breast cancer

2019 ◽  
Vol 30 ◽  
pp. v10
Author(s):  
M. Nuncia-Cantarero ◽  
C. Nieto-Jiménez ◽  
M. Burgos ◽  
J.C. Montero ◽  
A. Ocaña ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Cancer Cells ◽  
Triple Negative Breast Cancer ◽  
Tumour Growth ◽  
Triple Negative ◽  
Kinase Inhibitor

scholarly journals Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti–PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer

2019 ◽  
Vol 79 (10) ◽  
pp. 2669-2683 ◽  
Author(s):  
Canan Kasikara ◽  
Viralkumar Davra ◽  
David Calianese ◽  
Ke Geng ◽  
Thomas E. Spires ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Triple Negative Breast Cancer ◽  
Murine Model ◽  
Triple Negative ◽  
Kinase Inhibitor
Sign in / Sign up

Export Citation Format

Share Document